Tuberculosis (TB) or, more specifically, drug-resistant tuberculosis (MDR-TB), is shaping up to be one of India’s foremost health concerns in the future. Studies claim that India accounts for 27 percent of the world’s 10.4 million new TB cases and 29 percent of the 1.8 million deaths globally. India also accounts for sixteen percent of the …
Recent reports have surfaced of a new “super antibiotic” being developed by Japanese pharma company Shionogi. The term super antibiotic is problematic. At best, it could simply be wishful thinking. At worst, it could be a dangerous exaggeration in a world where antibiotic resistance is a looming threat to public health. Is appropriate language being …
A new weapon in the fight against tuberculosis may have been found during a trial in Belarus. The drug, named Bedaquiline, was shown to have more than a ninety percent cure rate when given in combination with other TB medicines. By comparison, current TB drugs were shown to be effective in just over half of cases. Like …
The Indian government is lagging behind in the issue of Tuberculosis (TB) treatment according to Harvard Medical School expert, Jennifer Furin in an email interview with The Hindu. The focal point of the matter is India’s lack of access to treatment via Bedaquiline, a drug capable of treating multi-drug resistant TB (MDR-TB). Created in response …
Health Issues India is a web portal that tracks key health stories and issues in India. On our website, you will find a guide to some of the latest trends, research, reports and journals on health. We provide original interviews and opinions of specialists as well as our own commentary on issues and events.
Subscribe our newsletter to stay updated
Copyright © 2023 | Health Issues India | All rights reserved.
